Literature DB >> 28670712

Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 1: Definition, risk factors and assessment.

Vincent Wai-Sun Wong1,2, Wah-Kheong Chan3, Shiv Chitturi4, Yogesh Chawla5, Yock Young Dan6, Ajay Duseja5, Jiangao Fan7, Khean-Lee Goh3, Masahide Hamaguchi8, Etsuko Hashimoto9, Seung Up Kim10, Laurentius Adrianto Lesmana11, Yu-Cheng Lin12, Chun-Jen Liu13, Yen-Hsuan Ni12, Jose Sollano14, Simon Kin-Hung Wong15, Grace Lai-Hung Wong1,2, Henry Lik-Yuen Chan1,2, Geoff Farrell4.   

Abstract

Entities:  

Keywords:  NAFLD; NASH; hepatocellular carcinoma; liver biopsy; liver stiffness measurement; metabolic syndrome; non-alcoholic steatohepatitis; obesity; transient elastography

Mesh：

Year:  2018        PMID： 28670712     DOI： 10.1111/jgh.13857

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN： 0815-9319            Impact factor:   4.029


× No keyword cloud information.
  105 in total

1.  Usefulness of Controlled Attenuation Parameter in Detecting and Monitoring Hepatic Steatosis with MRI-PDFF as Reference.

Authors:  Jing-Houng Wang; Hsin-You Ou; Yi-Hao Yen; Chien-Hung Chen; Sheng-Nan Lu
Journal:  Dig Dis Sci       Date:  2019-10-15       Impact factor: 3.199

Review 2.  Nonalcoholic Fatty Liver Disease and Recent Guideline Updates.

Authors:  Yumi Ando; Janice H Jou
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-02-01

Review 3.  Defining comprehensive models of care for NAFLD.

Authors:  Manuel Romero-Gómez; Jörn M Schattenberg; Jeffrey V Lazarus; Quentin M Anstee; Hannes Hagström; Kenneth Cusi; Helena Cortez-Pinto; Henry E Mark; Michael Roden; Emmanuel A Tsochatzis; Vincent Wai-Sun Wong; Zobair M Younossi; Shira Zelber-Sagi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-06-25       Impact factor: 46.802

Review 4.  Natural History of Simple Steatosis or Nonalcoholic Fatty Liver.

Authors:  Arka De; Ajay Duseja
Journal:  J Clin Exp Hepatol       Date:  2019-09-20

Review 5.  Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus.

Authors:  Giovanni Targher; Amedeo Lonardo; Christopher D Byrne
Journal:  Nat Rev Endocrinol       Date:  2017-12-29       Impact factor: 43.330

Review 6.  Screening of Cardiovascular Disease in Nonalcoholic Fatty Liver Disease: Whom and How?

Authors:  Narendra S Choudhary; Ajay Duseja
Journal:  J Clin Exp Hepatol       Date:  2019-02-15

Review 7.  Magnitude of Nonalcoholic Fatty Liver Disease: Eastern Perspective.

Authors:  Becky Ching-Yeung Yu; Deborah Kwok; Vincent Wai-Sun Wong
Journal:  J Clin Exp Hepatol       Date:  2019-02-07

Review 8.  Nonalcoholic Fatty Liver Disease: An Update on the Diagnosis.

Authors:  Jia-Zhen Zhang; Jing-Jing Cai; Yao Yu; Zhi-Gang She; Hongliang Li
Journal:  Gene Expr       Date:  2019-04-22

9.  Changing Nomenclature from Nonalcoholic Fatty Liver Disease to Metabolic Dysfunction-Associated Fatty Liver Disease - Not Only Premature But Also Confusing.

Authors:  Ajay Duseja; Sunil Taneja
Journal:  J Clin Exp Hepatol       Date:  2020-08-09

10.  Estimation of the Prevalence of Nonalcoholic Fatty Liver Disease in an Adult Population in Northern China Using the Data Mining Approach.

Authors:  TengFei Yang; Bo Zhao; Dongmei Pei
Journal:  Diabetes Metab Syndr Obes       Date:  2021-07-28       Impact factor: 3.168
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.